Translate to...

New therapy extends breast cancer survival rate, prevents reoccurrence

New therapy extends breast cancer survival rate, prevents reoccurrence

A new immunotherapy developed by researchers at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.